IIT-Madras and IRFC Launch India’s First Single-Cell Omics Research Lab
On November 18, 2025, the Indian Institute of Technology Madras (IIT-Madras) in collaboration with the Indian Railways Finance Corporation (IRFC) inaugurated India’s first Single Cell Omics Translational (SCOT) research laboratory. This groundbreaking facility is situated in the Department of Medical Sciences and Technology at IIT-Madras and aims to enhance the country’s capabilities in early diagnosis, drug discovery, biomarker development, and precision healthcare.
Funding and Support
The establishment of the SCOT lab has been made possible through a Corporate Social Responsibility (CSR) grant of Rs 10.83 crore from IRFC. This funding will enable the lab to be equipped with state-of-the-art instruments specifically designed for studying diseases at a single-cell level, which is crucial for advancing medical research.
Research Focus Areas
The SCOT lab will support a wide range of research initiatives, focusing on:
- Cancer
- Cardiovascular diseases
- Infectious and inflammatory illnesses
- Metabolic disorders
- Other non-communicable diseases
Significance of the Collaboration
V. Kamakoti, the Director of IIT-Madras, expressed that this collaboration with IRFC represents a significant milestone in enhancing India’s landscape for drug discovery and precision medicine. He emphasized that the new lab will facilitate the development of innovative solutions for early diagnostics and targeted therapies, which are essential for improving patient outcomes.
Contributions to Medical Research
Usha Venugopal, a Member (Finance) at the Ministry of Railways, highlighted the importance of this initiative in strengthening India’s medical research ecosystem. She pointed out that the SCOT lab will contribute to improved diagnosis and treatment methods, showcasing how effective partnerships between industry and academia can lead to impactful healthcare innovations.
Training and Development
Anubama Rajan from IIT-Madras emphasized the need for research platforms that connect molecular-level insights with real clinical outcomes. She stated that the SCOT lab will serve as a national training hub, bringing together doctors, scientists, and engineers. This collaborative environment is designed to accelerate translational research and develop advanced healthcare solutions tailored specifically for Indian patients.
Future Prospects
With the launch of the SCOT lab, IIT-Madras and IRFC aim to deepen India’s contributions to next-generation diagnostics, therapeutics, and precision medicine. This initiative is expected to pave the way for significant advancements in medical research and healthcare delivery in the country.
Conclusion
The establishment of India’s first Single Cell Omics Translational research lab marks a pivotal moment in the country’s medical research landscape. By leveraging advanced technologies and fostering collaboration between academia and industry, this initiative holds the promise of transforming healthcare in India, ultimately leading to better patient care and outcomes.
Note: This article is based on information available as of November 2025 and aims to provide an overview of the significant developments related to the SCOT lab at IIT-Madras.
